Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 283
Filter
3.
Br J Pharmacol ; 172(2): 642-53, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24827408

ABSTRACT

BACKGROUND AND PURPOSE: We recently found that PKCε was required for spinal analgesic synergy between two GPCRs, δ opioid receptors and α2 A adrenoceptors, co-located in the same cellular subpopulation. We sought to determine if co-delivery of µ and δ opioid receptor agonists would similarly result in synergy requiring PKCε. EXPERIMENTAL APPROACH: Combinations of µ and δ opioid receptor agonists were co-administered intrathecally by direct lumbar puncture to PKCε-wild-type (PKCε-WT) and -knockout (PKCε-KO) mice. Antinociception was assessed using the hot-water tail-flick assay. Drug interactions were evaluated by isobolographic analysis. KEY RESULTS: All agonists produced comparable antinociception in both PKCε-WT and PKCε-KO mice. Of 19 agonist combinations that produced analgesic synergy, only 3 required PKCε for a synergistic interaction. In these three combinations, one of the agonists was morphine, although not all combinations involving morphine required PKCε. Morphine + deltorphin II and morphine + deltorphin I required PKCε for synergy, whereas a similar combination, morphine + deltorphin, did not. Additionally, morphine + oxymorphindole required PKCε for synergy, whereas a similar combination, morphine + oxycodindole, did not. CONCLUSIONS AND IMPLICATIONS: We discovered biased agonism for a specific signalling pathway at the level of spinally co-delivered opioid agonists. As the bias is only revealed by an appropriate ligand combination and cannot be accounted for by a single drug, it is likely that the receptors these agonists act on are interacting with each other. Our results support the existence of µ and δ opioid receptor heteromers at the spinal level in vivo. LINKED ARTICLES: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.


Subject(s)
Analgesics, Opioid/pharmacology , Analgesics, Opioid/therapeutic use , Pain/drug therapy , Protein Kinase C-epsilon/metabolism , Receptors, Opioid, delta/metabolism , Receptors, Opioid, mu/metabolism , Animals , Behavior, Animal/drug effects , Drug Therapy, Combination , Female , Hot Temperature , Ligands , Male , Mice, Knockout , Morphine/pharmacology , Morphine/therapeutic use , Morpholines/pharmacology , Morpholines/therapeutic use , Oligopeptides/pharmacology , Oligopeptides/therapeutic use , Pain/metabolism , Protein Multimerization , Receptors, Opioid, delta/agonists , Receptors, Opioid, mu/agonists , Spinal Cord/metabolism
4.
Br J Pharmacol ; 172(2): 388-402, 2015 Jan.
Article in English | MEDLINE | ID: mdl-24641506

ABSTRACT

UNLABELLED: Opioid and α2 -adrenoceptor agonists are potent analgesic drugs and their analgesic effects can synergize when co-administered. These supra-additive interactions are potentially beneficial clinically; by increasing efficacy and/or reducing the total drug required to produce sufficient pain relief, undesired side effects can be minimized. However, combination therapies of opioids and α2 -adrenoceptor agonists remain underutilized clinically, in spite of a large body of preclinical evidence describing their synergistic interaction. One possible obstacle to the translation of preclinical findings to clinical applications is a lack of understanding of the mechanisms underlying the synergistic interactions between these two drug classes. In this review, we provide a detailed overview of the interactions between different opioid and α2 -adrenoceptor agonist combinations in preclinical studies. These studies have identified the spinal cord as an important site of action of synergistic interactions, provided insights into which receptors mediate these interactions and explored downstream signalling events enabling synergy. It is now well documented that the activation of both µ and δ opioid receptors can produce synergy with α2 -adrenoceptor agonists and that α2 -adrenoceptor agonists can mediate synergy through either the α2A or the α2C adrenoceptor subtypes. Current hypotheses surrounding the cellular mechanisms mediating opioid-adrenoceptor synergy, including PKC signalling and receptor oligomerization, and the evidence supporting them are presented. Finally, the implications of these findings for clinical applications and drug discovery are discussed. LINKED ARTICLES: This article is part of a themed section on Opioids: New Pathways to Functional Selectivity. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2015.172.issue-2.


Subject(s)
Receptors, Adrenergic, alpha-2/metabolism , Receptors, Opioid/metabolism , Adrenergic alpha-Agonists/pharmacokinetics , Adrenergic alpha-Agonists/pharmacology , Analgesia , Analgesics, Opioid/pharmacology , Animals , Drug Synergism , Humans
5.
JIMD Rep ; 10: 113-7, 2013.
Article in English | MEDLINE | ID: mdl-23430812

ABSTRACT

We describe the management and outcomes of pregnancy in two women affected with Maple syrup urine disease (MSUD). Both patients had classical disease diagnosed in the newborn period and were managed with low-protein diets and supplements, although compliance was moderately poor throughout life. Both pregnancies were complicated by poor compliance and one patient had a metabolic decompensation, which included seizures and profound encephalopathy, at the end of the first trimester. Peri-partum management required a coordinated team approach including a high-calorie and low-protein diet. Both patients had elevated leucine levels in the post-partum period - one due to mastitis and the other due to poor dietary and supplement compliance combined with uterine involution. On later review, leucine had returned to pre-pregnancy levels. Both infants were unaffected and have made normal developmental progress in the subsequent 1 to 2 years.

6.
J Occup Environ Hyg ; 9(5): 319-28, 2012.
Article in English | MEDLINE | ID: mdl-22500974

ABSTRACT

Many portable single-gas monitors are used for the detection of low concentrations of hydrogen sulfide (H(2)S) and sulfur dioxide (SO(2)) in the workplace. With the recent lowering of the H(2)S and SO(2) ACGIH® threshold limit value (TLV®) the ability of these devices to selectively respond to these new lower levels is not well documented in petroleum industry environments, which often have potential interfering gases and vapors present as well as varying environmental conditions. Tests were carried out to measure the ability of various monitors with their respective sensors to correctly quantify and respond to H(2)S and SO(2) in a simulated petroleum industry environment. This included the identification of selected interference effects and estimation of the reliable lower limit of detection for real workplace environments. None of the H(2)S monitors responded at 0.1 times the new TLV (0.1 ppm), only some of them responded at the new TLV concentration (1 ppm), and all the monitors exposed to five times the new TLV (5 ppm) responded with reasonable accuracy. There was generally little effect of interferent gases and vapors on the H(2)S monitors. None of the SO(2) monitors responded at 0.1 and 1 times the new TLV (0.025 ppm and 0.25 ppm) concentrations, and all but one of them exposed to five times the new TLV (1.25 ppm) responded. There was much greater cross-sensitivity to interferents at the tested concentrations with the SO(2) monitors, which responded to six out of eight of the interferents tested. Results demonstrate that these monitors cannot reliably alarm and measure H(2)S or SO(2) concentrations at the new TLVs with an acceptable degree of accuracy. However, these monitors are designed to alarm as a safety device; these results do not change this important function.


Subject(s)
Air Pollutants, Occupational/analysis , Environmental Monitoring/instrumentation , Equipment and Supplies/standards , Extraction and Processing Industry , Hydrogen Sulfide/analysis , Sulfur Dioxide/analysis , Petroleum , Sensitivity and Specificity , Threshold Limit Values
7.
Aust Vet J ; 89(4): 122-30, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21418168

ABSTRACT

OBJECTIVE: To report the occurrence and pathology of porcine circovirus type 2 (PCV2)-associated disease (PCVAD) of postweaning pigs in two Australian pig herds. METHODS: Mortality data from two commercial piggeries that experienced higher than normal postweaning illthrift and mortalities were examined. Gross and histopathological examinations were performed on the index cases, and at weekly intervals thereafter for a period of 10 weeks. Specimens were submitted to the laboratory for routine diagnostic testing and for exclusion of porcine reproductive and respiratory syndrome virus (PRRSV). The genomes of two strains of PCV2 isolated during testing were sequenced. RESULTS: Mortality rates in weaned, 5-12-week-old pigs spiked significantly during mid to late 2007. This increase in the mortalities was mainly attributed to salmonella-associated diarrhoea and illthrift. Salmonellosis was diagnosed in 73/110 cases inclusive of both piggeries. Many pigs also had chronic granulomatous lymphadenitis and diffuse histiocytic interstitial pneumonia consistent with PCVAD and associated with varying amounts of PCV2 antigen and inclusion bodies. All samples tested for PRRSV were negative. Sequence analysis of the PCV2 isolates showed strain differences between piggeries. CONCLUSION: This report describes the first outbreaks of PCVAD in growing pigs in Western Australia (WA) and describes lesions not previously seen in this laboratory. It also describes the first isolation of a PCV2 group 1 virus in WA associated with PCVAD. Although the outbreaks of PCVAD occurred with concurrent salmonellosis, the two diseases were unrelated. Neither of the outbreaks met the Australian case definition for the diagnosis of postweaning multisystemic wasting syndrome.


Subject(s)
Circoviridae Infections/veterinary , Circovirus/isolation & purification , Salmonella Infections, Animal/epidemiology , Swine Diseases/epidemiology , Animals , Animals, Newborn , Circoviridae Infections/epidemiology , Comorbidity , Disease Outbreaks/veterinary , Female , Male , Swine , Weaning , Western Australia/epidemiology
8.
J Virol Methods ; 147(1): 61-6, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17889378

ABSTRACT

International trade in pig meat has resulted in some countries placing restrictions on the importation of pig meat, with requirements for cooking of imported meat to destroy viral agents. This study investigated the in vitro resistance of an Australian strain of porcine circovirus type 2 (PCV2), the causative agent of post-weaning multisystemic wasting syndrome (PMWS), to heat treatment. The viability of the virus in cell cultures was determined by a combination of reverse transcriptase polymerase chain reaction (RT-PCR) to detect viral transcripts, and immunohistochemistry (IHC) to visualize viral capsid antigen. PCV2 retained infectivity when heated at 75 degrees C for 15 min but was inactivated by heating at 80 degrees C and above for 15 min. The results provide important information on the thermal tolerance of PCV2, which can be taken into account in risk assessments for trade in pig meat and porcine-derived biological products.


Subject(s)
Antigens, Viral/analysis , Circovirus/physiology , Hot Temperature , Immunohistochemistry/methods , Reverse Transcriptase Polymerase Chain Reaction/methods , Animals , Antigens, Viral/immunology , Capsid Proteins/analysis , Cells, Cultured , Virus Replication
9.
Maturitas ; 61(1-2): 27-33, 2008.
Article in English | MEDLINE | ID: mdl-19434877

ABSTRACT

Plants contain compounds with oestrogen--like action called phytoestrogens. Soy contains daidzin, a potent phytoestrogen, and wheat flour contains less potent enterolactones. We aimed to show in 58 postmenopausal women (age 54, range 30-70 years) with at least 14 hot flushes per week, that their daily diet supplemented with soy flour (n = 28) could reduce flushes compared with wheat flour (n = 30) over 12 weeks when randomised and double blind. Hot flushes significantly decreased in the soy and wheat flour groups (40% and 25% reduction, respectively < 0.001 for both) with a significant rapid response in the soy flour group in 6 weeks (P < 0.001) that continued. Menopausal symptom score decreased significantly in both groups (P < 0.05). Urinary daidzein excretion confirmed compliance. Vaginal cell maturation, plasma lipids and urinary calcium remained unchanged. Serum FSH decreased and urinary hydroxyproline increased in the wheat flour group.

10.
J Food Sci ; 72(9): M431-6, 2007 Nov.
Article in English | MEDLINE | ID: mdl-18034738

ABSTRACT

The objective of this study was to enhance calcium solubility and bioavailability from calcium-fortified soymilk by fermentation with 7 strains of Lactobacillus, namely, L. acidophilus ATCC 4962, ATCC33200, ATCC 4356, ATCC 4461, L. casei ASCC 290, L. plantarum ASCC 276, and L. fermentum VRI-003. The parameters that were used are viability, pH, calcium solubility, organic acid, and biologically active isoflavone aglycone content. Calcium-fortified soymilk made from soy protein isolate was inoculated with these probiotic strains, incubated for 24 h at 37 degrees C, then stored for 14 d at 4 degrees C. Soluble calcium was measured using atomic absorption spectrophotometry (AA). Organic acids and bioactive isoflavone aglycones, including diadzein, genistein, and glycetein, were measured using HPLC. Viability of the strains in the fermented calcium-fortified soymilk was > 8.5 log(10) CFU/g after 24 h fermentation and this was maintained for 14-d storage at 4 degrees C. After 24 h, there was a significant increase (P < 0.05) in soluble calcium. L. acidophilus ATCC 4962 and L. casei ASCC 290 demonstrated the highest increase with 89.3% and 87.0% soluble calcium after 24 h, respectively. The increase in calcium solubility observed was related to lowered pH associated with production of lactic and acetic acids. Fermentation significantly increased (P < 0.05) the level of conversion of isoflavones into biologically active aglycones, including diadzein, genistein, and glycetein. Our results show that fermenting calcium-fortified soymilk with the selected probiotics can potentially enhance the calcium bioavailability of calcium-fortified soymilk due to increased calcium solubility and bioactive isoflavone aglycone enrichment.


Subject(s)
Calcium/chemistry , Carboxylic Acids/metabolism , Food, Fortified , Isoflavones/metabolism , Lactobacillus/metabolism , Soy Milk/metabolism , Biological Availability , Carboxylic Acids/analysis , Chromatography, High Pressure Liquid , Colony Count, Microbial , Fermentation/physiology , Food Handling/methods , Food Microbiology , Genistein/metabolism , Hydrogen-Ion Concentration , Probiotics/metabolism , Solubility , Soy Milk/chemistry , Spectrophotometry, Atomic , Temperature , Time Factors
11.
Vet Microbiol ; 121(1-2): 18-28, 2007 Mar 31.
Article in English | MEDLINE | ID: mdl-17208393

ABSTRACT

A nested multiplex PCR was developed as a rapid (<12h), sensitive test for the simultaneous identification of equine herpesviruses (EHV1, EHV4, EHV2 and EHV5) in clinical samples from horses. Peripheral blood and nasal swab (NS) samples from 205 weanling Thoroughbred foals on 6 different studs over 3 consecutive seasons and from 92 adult horses without clinical signs of respiratory disease were examined using direct multiplex PCR of clinical samples (direct PCR) and conventional cell culture with differentiation of EHV in cell cultures by multiplex PCR. Multiplex PCR proved a sensitive and specific technique for the detection of EHV in cell culture and clinical samples. The technique described appeared equally sensitive as one using a single set of primers for individual EHV but reduced labour and reagent costs. Cell cultures showing cytopathic effect (CPE) were always positive for EHV on PCR. EHV were also detected by multiplex PCR in 11 samples which failed to show CPE. By a combination of multiplex PCR and cell culture or direct multiplex PCR, the presence of up to three EHV in the same sample was detected. Overall, EHV5 was detected by direct multiplex PCR of peripheral blood mononuclear cells (PBMC) and/or NS samples from 78% of foals and 47% of adult horses. Repeated sampling or cell culture in combination with multiplex PCR and with the incorporation of IL-2 in culture medium increased the sensitivity for detection of EHV in PBMC and demonstrated that EHV5 DNA could be identified in PBMC from 89% of foals and 100% of adult horses. EHV2 was identified from approximately 30% of foals, but was more frequently identified in samples from 17 foals with mild respiratory disease and was isolated infrequently from adult horses. EHV1 and EHV4 were identified uncommonly in any population in the current study.


Subject(s)
Herpesviridae Infections/veterinary , Herpesviridae Infections/virology , Herpesviridae/isolation & purification , Horse Diseases/virology , Polymerase Chain Reaction/veterinary , Animals , DNA, Viral/chemistry , DNA, Viral/genetics , Herpesviridae/genetics , Herpesviridae Infections/blood , Horse Diseases/diagnosis , Horses , Polymerase Chain Reaction/methods , Sensitivity and Specificity
12.
Eur J Clin Nutr ; 61(3): 438-41, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17021598

ABSTRACT

OBJECTIVE: To study the effects of consuming isoflavone aglycone-enriched soymilk fermented by bifidobacteria on urinary excretion of equol with respect to fermentation, daidzein dose, supplementation duration and background diet. DESIGN: Double-blind crossover pilot study comprising three 14-day supplementation periods separated by a washout. SETTING: Victoria University, Melbourne, Australia. SUBJECTS: Sixteen postmenopausal women. INTERVENTION: SUBJECTS randomized into two groups consuming either fermented (FS) or non-fermented soymilk (NFS), ingested three daily dosages of daidzein via soymilk and collected pooled urine specimens. Daidzein and equol were quantified using high-performance liquid chromatography. RESULTS: After 14-days supplementation six women (38%) excreted equol (>1 micromol equol/day), including four from the FS group, two of whom were classified as non-producers at day 4. Bifidobacteria ingestion, composition of daidzein and its glucosides, and carbohydrate intake appeared to influence equol formation among equol producers. CONCLUSIONS: Pilot-study group mean urinary equol excretion results provided insufficient evidence (P>0.05) that FS consumption instigates equol production in women predetermined as non-producers.


Subject(s)
Bifidobacterium/metabolism , Food Handling/methods , Isoflavones/urine , Phytoestrogens/urine , Soy Milk/administration & dosage , Chromatography, High Pressure Liquid/methods , Cross-Over Studies , Dose-Response Relationship, Drug , Equol , Female , Fermentation , Humans , Isoflavones/metabolism , Middle Aged , Phytoestrogens/metabolism , Pilot Projects , Postmenopause/urine , Probiotics , Soy Milk/chemistry
13.
Aust Vet J ; 84(12): 421-5; discussion 416, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17156322

ABSTRACT

OBJECTIVE: As post-weaning multi-systemic wasting syndrome (PMWS) has not been identified within Australia, to determine if the absence of disease was associated with genetic differences between the strains of porcine circovirus (PCV) present in Australia and those from countries in association with PMWS. DESIGN: Pig tissues were obtained from weaned pigs found dead or presenting with clinical signs of illthrift and also from neonatal pigs with congenital tremors and used as a source of virus DNA for sequence analysis. PROCEDURE: DNA was extracted from the tissues and PCV detected by polymerase chain reaction (PCR). PCR with PCV type-specific primers was used to amplify the entire genome from selected tissues. The genomes of three strains of PCV1 and seven strains of PCV2 from three Australian states were sequenced and subjected to phylogenetic analysis using standard procedures. RESULTS: The three Australian PCV1 strains had 98 to 99% nucleotide identity to strains in other countries and the seven Australian PCV2 strains had 94 to 99% identity to PCV2 strains in other countries where PMWS has occurred. Six of the seven Australian PCV2 strains were genetically similar to each other, while the seventh was more distantly related. There were no consistent differences in the predicted amino acid sequence of the Australian strains of PCV2 and strains associated with PMWS in other countries. CONCLUSION: There were no consistent differences between Australian strains of PCV and those that have been associated with PMWS in other countries and it appears likely that other factors are responsible for the absence of PMWS in Australia.


Subject(s)
Circoviridae Infections/veterinary , Circovirus/classification , Circovirus/genetics , DNA, Viral/analysis , Phylogeny , Swine Diseases/virology , Animals , Base Sequence , Circoviridae Infections/virology , Genome, Viral , Molecular Sequence Data , Polymerase Chain Reaction/veterinary , Swine
14.
J Inherit Metab Dis ; 28(5): 613-26, 2005.
Article in English | MEDLINE | ID: mdl-16151892

ABSTRACT

The natural history of inborn errors of protein metabolism and the long-term effects of prescribed semisynthetic therapeutic diets are largely unknown. We assessed body composition, measuring body-fat mass and distribution, fat-free mass, total body protein, total body potassium, bone density and skeletal muscle mass, in young adults (age > 18 years; 6 female, 5 male) with inborn errors of protein metabolism maintained on long-term low-protein diets, compared with controls. Female patients were significantly shorter (159.4 cm vs 169.2 cm, p = 0.013) and had higher BMI (25.3 vs 22.0 kg/m2, p < 0.05), abdominal to gluteal circumference ratio (0.84 vs 0.73, p = 0.011), percentage body fat (42.3% vs 29.5%, p < 0.005) and ratio of central to peripheral body fat (1.15 vs 0.86, p < 0.05) than controls. Male patients had lower height-adjusted total body bone mineral content (0.9 vs 1.02 g/m2, p < 0.04) and skeletal muscle mass (31.1 vs 36.3 kg, p < 0.04) than controls. Compared with controls, patients'nitrogen index was significantly lower (0.91 vs 1.03, p < 0.01), consistent with lower total body protein. Potassium index was significantly higher (121.2% vs 110.4%, p < 0.03), consistent with higher body cell mass, or intracellular water. Documentation of body composition in larger patient series is important to elucidate whether these results reflect increased risks (hence opportunities for prevention) of bone disease, metabolic syndrome and cardiovascular disease in this population.


Subject(s)
Amino Acid Metabolism, Inborn Errors/diet therapy , Amino Acid Metabolism, Inborn Errors/pathology , Body Composition , Brain Diseases, Metabolic, Inborn/diet therapy , Brain Diseases, Metabolic, Inborn/pathology , Food, Formulated , Proteins/chemistry , Absorptiometry, Photon , Adipose Tissue , Adolescent , Adult , Amino Acid Metabolism, Inborn Errors/physiopathology , Anthropometry , Body Mass Index , Bone Density , Brain Diseases, Metabolic, Inborn/physiopathology , Case-Control Studies , Diet, Protein-Restricted , Female , Humans , Male , Muscle, Skeletal/pathology , Pilot Projects , Potassium/metabolism , Risk Factors
15.
Aust Vet J ; 83(5): 300-4, 2005 May.
Article in English | MEDLINE | ID: mdl-15957393

ABSTRACT

OBJECTIVE: To determine if porcine circovirus (PCV) type 1 (PCV1) or type 2 (PCV2) is present in the Australian pig herd, to conduct preliminary genetic characterisation of any viruses detected, and to determine if there is any obvious virological reason why post-weaning multisystemic wasting disease (PMWS), associated with PCV infection in other countries, has not been detected in Australia. DESIGN: Serum samples were collected from 14 randomly selected pig farms in Western Australia and used for detection of PCV antibody. Additional samples from one farm were obtained at 2-week intervals from pigs between 2 and 12 weeks of age to detect any age-associated variations in prevalence of infection. Veterinary practitioners from four Australian states submitted tissues of dead or unthrifty weaned pigs, and these were examined for evidence of PCV1 and PCV2 infection. PROCEDURE: Sera were tested for antibody to PCV using an indirect immunofluorescence assay (IFA). Tissues were tested for PCV1 and PCV2 genomic material using a multiplex PCR. RESULTS: PCV antibody was detected in approximately 30% of Western Australian pigs tested. PCV1 DNA was detected in tissue samples from Western Australia, South Australia and New South Wales and PCV2 DNA was detected in tissue samples from Western Australia, New South Wales and Queensland. Sequence analysis of the PCR products indicated the PCV1 and PCV2 present in Australia were very similar to strains in other countries where PMWS is endemic. CONCLUSION: Both PCV1 and PCV2 are present in Australia and the viruses present appear similar to those in countries with PMWS. The absence of PCV2-associated PMWS in Australia may be due to absence of essential secondary factors required for PCV2 to produce PMWS.


Subject(s)
Circoviridae Infections/veterinary , Circovirus/isolation & purification , Swine Diseases/diagnosis , Age Factors , Animals , Antibodies, Viral/blood , Circoviridae Infections/diagnosis , Circoviridae Infections/epidemiology , Circovirus/genetics , Circovirus/immunology , DNA, Viral/analysis , DNA, Viral/chemistry , Female , Fluorescent Antibody Technique, Indirect/veterinary , Male , Polymerase Chain Reaction/methods , Polymerase Chain Reaction/veterinary , Sequence Analysis, DNA/veterinary , Seroepidemiologic Studies , Swine , Swine Diseases/epidemiology , Swine Diseases/virology , Western Australia/epidemiology
16.
Neuroscience ; 132(2): 479-91, 2005.
Article in English | MEDLINE | ID: mdl-15802198

ABSTRACT

A nociceptive role for tumor necrosis factor-alpha (TNF-alpha) in naive mice and in mice with fibrosarcoma tumor-induced primary hyperalgesia was investigated. The presence of TNF-alpha mRNA was confirmed in tumor site homogenates by reverse transcription-polymerase chain reaction (RT-PCR), and examination of TNF-alpha protein levels in tumor-bearing mice indicated a significantly higher concentration of this cytokine in tumor microperfusates and tumor site homogenates compared with that obtained from a similar site on the contralateral limb or in naive mice. Intraplantar injection of TNF-alpha into naive or fibrosarcoma tumor-bearing mice induced mechanical hypersensitivity, as measured by withdrawal responses evoked by von Frey monofilaments. This hypersensitivity suggests that TNF-alpha can excite or sensitize primary afferent fibers to mechanical stimulation in both naive and tumor-bearing mice. In addition, the hyperalgesia produced by TNF-alpha was completely eliminated when the injected TNF-alpha was pre-incubated with the soluble receptor antagonist TNFR:Fc. Importantly, pre-implantation systemic as well as post-implantation intra-tumor injection of TNFR:Fc partially blocked the mechanical hyperalgesia, indicating that local production of TNF-alpha may contribute to tumor-induced nociception.


Subject(s)
Fibrosarcoma/metabolism , Neoplasms, Experimental/metabolism , Pain/metabolism , Tumor Necrosis Factor-alpha/metabolism , Animals , Behavior, Animal , Cell Line, Tumor , Fibrosarcoma/complications , Gene Expression Regulation, Neoplastic/physiology , Immunohistochemistry/methods , Male , Mice , Mice, Inbred C3H , Neoplasm Transplantation , Neoplasms, Experimental/complications , Pain/etiology , Pain Measurement/methods , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction/methods , Tumor Necrosis Factor-alpha/genetics
17.
J Neurosci ; 21(23): 9355-66, 2001 Dec 01.
Article in English | MEDLINE | ID: mdl-11717369

ABSTRACT

This paper describes a model of tumor-induced bone destruction and hyperalgesia produced by implantation of fibrosarcoma cells into the mouse calcaneus bone. Histological examination indicates that tumor cells adhere to the bone edge as early as post-implantation day (PID) 3, but osteolysis does not begin until PID 6, correlating with the development of hyperalgesia. C3H/He mice exhibit a reproducible hyperalgesia to mechanical and cold stimuli between PID 6 and 16. These behaviors are present but significantly reduced with subcutaneous implantation that does not involve bone. Systemic administration of morphine (ED(50) 9.0 mg/kg) dose-dependently attenuated the mechanical hyperalgesia. In contrast, bone destruction and hypersensitivity were not evident in mice implanted with melanoma tumors or a paraffin mass of similar size. A novel microperfusion technique was used to identify elevated levels of the putative algogen endothelin (ET) in perfusates collected from the tumor sites of hyperalgesic mice between PID 7 and 12. Increased ET was evident in microperfusates from fibrosarcoma tumor-implanted mice but not from melanoma tumor-implanted mice, which are not hyperalgesic. Intraplantar injection of ET-1 in naive and, to a greater extent, fibrosarcoma tumor-bearing mice produced spontaneous pain behaviors, suggesting that ET-1 activates primary afferent fibers. Intraplantar but not systemic injection of the ET-A receptor antagonist BQ-123 partially blocked tumor-associated mechanical hyperalgesia, indicating that ET-1 contributes to tumor-induced nociception. This model provides a unique approach for quantifying the behavioral, biochemical, and electrophysiological consequences of tumor-nerve interactions.


Subject(s)
Disease Models, Animal , Fibrosarcoma/physiopathology , Melanoma, Experimental/physiopathology , Neoplasms, Experimental/physiopathology , Pain/physiopathology , Peripheral Nerves/physiopathology , Animals , Behavior, Animal , Calcaneus/pathology , Calcaneus/surgery , Crosses, Genetic , Endothelin-1/adverse effects , Endothelin-1/biosynthesis , Endothelin-1/metabolism , Fibrosarcoma/complications , Fibrosarcoma/pathology , Hindlimb/pathology , Hindlimb/physiopathology , Hyperalgesia/diagnosis , Hyperalgesia/etiology , Hyperalgesia/physiopathology , Melanoma, Experimental/complications , Melanoma, Experimental/pathology , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Neoplasm Transplantation , Neoplasms, Experimental/complications , Neoplasms, Experimental/pathology , Pain/diagnosis , Pain/etiology , Pain Measurement/drug effects , Peripheral Nerves/pathology , Physical Stimulation , Tumor Cells, Cultured
18.
J Neurosci ; 21(23): 9367-76, 2001 Dec 01.
Article in English | MEDLINE | ID: mdl-11717370

ABSTRACT

We used a murine model to investigate functional interactions between tumors and peripheral nerves that may contribute to pain associated with cancer. Implantation of fibrosarcoma cells in and around the calcaneus bone produced mechanical hyperalgesia of the ipsilateral paw. Electrophysiological recordings from primary afferent fibers in control and hyperalgesic mice with tumor revealed the development of spontaneous activity (0.2-3.4 Hz) in 34% of cutaneous C-fibers adjacent to the tumor (9-17 d after implantation). C-fibers in tumor-bearing mice exhibited a mean decrease in heat threshold of 3.5 +/- 0.10 degrees C. We also examined innervation of the skin overlying the tumor. Epidermal nerve fibers (ENFs) were immunostained for protein gene product 9.5, imaged using confocal microscopy, and analyzed in terms of number of fibers per millimeter of epidermal length and branching (number of nodes per fiber). Divergent morphological changes were linked to tumor progression. Although branching of ENFs increased significantly relative to control values, in later stages (16-24 d after implantation) of tumor growth a sharp decrease in the number of ENFs was observed. This decay of epidermal innervation of skin over the tumor coincided temporally with gradual loss of electrophysiological activity in tumor-bearing mice. The development of spontaneous activity and sensitization to heat in C-fibers and increased innervation of cutaneous structures within the first 2 weeks of tumor growth suggest activation and sensitization of a proportion of C-fibers. The decrease in the number of ENFs observed in later stages of tumor development implicates neuropathic involvement in this model of cancer pain.


Subject(s)
Disease Models, Animal , Fibrosarcoma/physiopathology , Neoplasms, Experimental/physiopathology , Nerve Fibers , Neurons, Afferent , Pain/physiopathology , Peripheral Nerves/physiopathology , Animals , Calcaneus/pathology , Calcaneus/surgery , Disease Progression , Electrophysiology , Epidermis/innervation , Epidermis/pathology , Epidermis/physiopathology , Fibrosarcoma/complications , Fibrosarcoma/pathology , Hindlimb/pathology , Hindlimb/physiopathology , Hyperalgesia/diagnosis , Hyperalgesia/etiology , Hyperalgesia/physiopathology , Male , Mice , Mice, Inbred C3H , Neoplasm Transplantation , Neoplasms, Experimental/complications , Neoplasms, Experimental/pathology , Nerve Fibers/pathology , Neurons, Afferent/pathology , Pain/diagnosis , Pain/etiology , Pain Measurement , Peripheral Nerves/pathology , Physical Stimulation , Tumor Cells, Cultured
19.
J Pharmacol Exp Ther ; 299(1): 6-11, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11561057

ABSTRACT

The opioid peptide dynorphin has been demonstrated to be both nociceptive and antinociceptive. This article will review the potential mechanisms through which dynorphin contributes to spinally mediated nociception. Specifically, we will examine the interaction of dynorphin with multiple sites on the NMDA receptor complex. Dynorphin-induced opioid activity is generally inhibitory, with a tendency to impede nociceptive signals and serve in a neuroprotective capacity. In contrast, dynorphin's interaction with multiple sites on the NMDA receptor complex produces excitatory responses resulting in nociceptive and even toxic effects. Thus, it is hypothesized that dynorphin has both physiological and pathological roles in acute and chronic pain states.


Subject(s)
Analgesics, Opioid/pharmacology , Dynorphins/pharmacology , Analgesics, Opioid/metabolism , Animals , Dynorphins/metabolism , Humans , Receptors, N-Methyl-D-Aspartate/drug effects , Receptors, Opioid/drug effects
20.
Clin Diagn Lab Immunol ; 8(2): 283-7, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238209

ABSTRACT

Bovine immunodeficiency virus (BIV) and Jembrana disease virus (JDV) are bovine lentiviruses that are closely related genetically. A recombinant fusion protein containing the capsid protein of BIV expressed in Escherichia coli was used to immunize mice and produce monoclonal antibodies. Six hybridomas specific for BIV capsid protein were identified, and one antibody, designated 10H1, was characterized further. Competitive binding assays were performed to analyze the topography of antigenic determinants by enzyme-linked immunosorbent assay and demonstrated the existence of at least three distinct antigenic determinants on capsid protein. The monoclonal antibody reacted specifically with both BIV capsid and the recombinant fusion protein in Western immunoblot analyses. However, it did not react with the recombinant capsid fusion protein of JDV, indicating that BIV contains at least one unique epitope in the capsid protein that is absent in JDV. Further mapping of the epitope by chemical cleavage analysis identified that the epitope is located at the 6.4-kDa N terminus of the 29-kDa capsid protein. This monoclonal antibody assay will be valuable for distinguishing the two closely related lentiviruses by Western blotting.


Subject(s)
Antibodies, Monoclonal/immunology , Antibody Specificity , Cattle Diseases/diagnosis , Immunodeficiency Virus, Bovine/immunology , Lentivirus Infections/diagnosis , Animals , Antigens, Neoplasm , Capsid/immunology , Cattle , Cattle Diseases/immunology , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Hybridomas , Immunodeficiency Virus, Bovine/isolation & purification , Immunoglobulin kappa-Chains , Lentivirus Infections/immunology , Lentivirus Infections/veterinary , Mice , Mice, Inbred BALB C , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL